Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy - PubMed (original) (raw)

. 1992 Nov 27;258(5087):1491-4.

doi: 10.1126/science.1279812.

Affiliations

• PMID: 1279812
• DOI: 10.1126/science.1279812

Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy

A Gaur et al. Science. 1992.

Abstract

Experimental autoimmune encephalomyelitis (EAE), a demyelinating disease of the central nervous system that can be induced in susceptible strains of mice by immunization with myelin basic protein (MBP) or its immunodominant T cell determinants, serves as a model of human multiple sclerosis. Tolerance to MBP in adult mice was induced by intraperitoneal injection of synthetic peptides of immunodominant determinants of MBP and prevented MBP-induced EAE. Furthermore, tolerance-inducing regimens of peptides administered to mice after the disease had begun (10 days after induction with MBP) blocked the progression and decreased the severity of EAE. Peptide-induced tolerance resulted from the induction of anergy in proliferative, antigen-specific T cells.

PubMed Disclaimer

Similar articles

• Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide.
  Marusić S, Tonegawa S. Marusić S, et al. J Exp Med. 1997 Aug 18;186(4):507-15. doi: 10.1084/jem.186.4.507. J Exp Med. 1997. PMID: 9254649 Free PMC article.
• Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
  Kono DH, Urban JL, Horvath SJ, Ando DG, Saavedra RA, Hood L. Kono DH, et al. J Exp Med. 1988 Jul 1;168(1):213-27. doi: 10.1084/jem.168.1.213. J Exp Med. 1988. PMID: 2456367 Free PMC article.
• Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
  Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H. Liu JQ, et al. Int Immunol. 1998 Aug;10(8):1139-48. doi: 10.1093/intimm/10.8.1139. Int Immunol. 1998. PMID: 9723700
• Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis.
  Martin R, Bielekova B, Gran B, McFarland HF. Martin R, et al. J Neural Transm Suppl. 2000;(60):361-73. doi: 10.1007/978-3-7091-6301-6_26. J Neural Transm Suppl. 2000. PMID: 11205154 Review.
• Myelin basic protein: structure, function and antigenic determinants.
  Hashim GA. Hashim GA. Immunol Rev. 1978;39:60-107. doi: 10.1111/j.1600-065x.1978.tb00397.x. Immunol Rev. 1978. PMID: 75170 Review. No abstract available.

Cited by

• Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.
  Song Y, Li J, Wu Y. Song Y, et al. Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8. Signal Transduct Target Ther. 2024. PMID: 39362875 Free PMC article. Review.
• Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
  Akinfenwa O, Huang HJ, Linhart B, Focke-Tejkl M, Vrtala S, Poroshina A, Nikonova A, Khaitov M, Campion NJ, Eckl-Dorna J, Niederberger-Leppin V, Kratzer B, Tauber PA, Pickl WF, Kundi M, Campana R, Valenta R. Akinfenwa O, et al. Front Immunol. 2021 Oct 26;12:744544. doi: 10.3389/fimmu.2021.744544. eCollection 2021. Front Immunol. 2021. PMID: 34795666 Free PMC article.
• The role of prolactin in the pathogenesis of autoimmune disease.
  Berczi I. Berczi I. Endocr Pathol. 1993 Dec;4(4):178-195. doi: 10.1007/BF02915460. Endocr Pathol. 1993. PMID: 32138433 Review.
• Modulating the immune system through nanotechnology.
  Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ. Dacoba TG, et al. Semin Immunol. 2017 Dec;34:78-102. doi: 10.1016/j.smim.2017.09.007. Epub 2017 Oct 9. Semin Immunol. 2017. PMID: 29032891 Free PMC article. Review.
• A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides.
  Kostadinova AI, Meulenbroek LA, van Esch BC, Hofman GA, Garssen J, Willemsen LE, Knippels LM. Kostadinova AI, et al. Front Immunol. 2017 Jan 12;7:673. doi: 10.3389/fimmu.2016.00673. eCollection 2016. Front Immunol. 2017. PMID: 28127297 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal